492 related articles for article (PubMed ID: 19609736)
1. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
Lespessailles E; Jaffré C; Beaupied H; Nanyan P; Dolléans E; Benhamou CL; Courteix D
Calcif Tissue Int; 2009 Aug; 85(2):146-57. PubMed ID: 19609736
[TBL] [Abstract][Full Text] [Related]
2. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
[TBL] [Abstract][Full Text] [Related]
3. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
4. Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association?
Lespessailles E; Jaffré C; Rochefort GY; Dolléans E; Benhamou CL; Courteix D
Lipids; 2010 Apr; 45(4):337-44. PubMed ID: 20229125
[TBL] [Abstract][Full Text] [Related]
5. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
Bonnet N; Beaupied H; Vico L; Dolleans E; Laroche N; Courteix D; Benhamou CL
J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
[TBL] [Abstract][Full Text] [Related]
7. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
[TBL] [Abstract][Full Text] [Related]
9. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
10. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
11. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
[TBL] [Abstract][Full Text] [Related]
17. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
18. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
19. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
20. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]